Acute coronary syndrome - prasugrel with PCI (review TA182): Evaluation report

Please be advised that the format of evaluation reports shared on the NICE website has recently changed, for ease of user navigation between individual documents contained in the report.

It is a requirement of the new (PDF portfolio) format that Adobe Reader is used to view the document. Please follow the link at the bottom of this page to download Adobe Reader if required.

If you have any feedback on the new format please contact the Project Manager for this appraisal.

01.  Overview prepared by NICE

02.  Assesment Report prepared by LRiG

03.  Comments on the Assessment Report - AstraZeneca

04.  Comments on the Assessment Report - Lilly UK

05.  Clinical expert personal perspective - Curzen

06.  Patient expert personal perspective - Hartshorne-Evans

07.  Clinical expert personal perspective - Kinnaird

08.  Executive summary of technology manufacturers submission - Lilly UK

09.  Consultee submission - British Cardiovascular Intervention Society

10.  First addendum to the Assessment report - LriG

11.  Second addendum to the Assessment Report - LriG

12.  Third addendum to the Assesment Report - LriG

13.  Erratum to the Assessment Report - LRiG


If you cannot open this document, you may have to save to your device and open.


This page was last updated: 28 March 2014